Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC).
暂无分享，去创建一个
I. Tannock | A. Evans | Lisa I. Wang | B. Wouters | A. Hansen | J. Knox | A. Prawira | F. Vera-Badillo | S. Sridhar | E. Chen | A. Joshua | A. Templeton | Susie Tan | Lisa Wang